Related Experiment Video

Updated: May 14, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro

Daniela E Oprea-Lager1, Irene V Bijnsdorp, Reindert J A VAN Moorselaar

  • 1Department of Radiology and Nuclear Medicine, Department of Urology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands. aa.geldof@vumc.nl

Anticancer Research
|February 9, 2013
PubMed
Abstract

Insights

Cabazitaxel is more effective than docetaxel in prostate cancer cells expressing ATP-cassette binding protein 4 (ABCC4). Inhibiting ABCC4 reverses docetaxel resistance, highlighting its role in multidrug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Prostate cancer treatment often involves chemotherapy.
  • Docetaxel resistance is a significant clinical challenge.
  • Multidrug resistance (MDR) mechanisms, like ABCC4, impede treatment efficacy.

Purpose of the Study:

  • To assess cabazitaxel's efficacy in docetaxel-resistant prostate cancer models.
  • To investigate the role of ATP-cassette binding protein 4 (ABCC4) in this resistance.
  • To determine if ABCC4 is a viable target for overcoming MDR.

Main Methods:

  • Utilized PC3 and R3327-MATLyLu (MLL) cell lines for sensitivity assays.
  • Measured drug sensitivity using the sulforhodamine B (SRB) assay.
  • Examined ABCC4 expression via western blotting and functional impact using the MK571 inhibitor.

Main Results:

  • Docetaxel-resistant MLL cells exhibited high ABCC4 expression (4.5-fold increase vs. cabazitaxel; p<0.001).
  • Non-resistant PC3 cells showed no detectable ABCC4.
  • ABCC4 inhibition in MLL cells reduced docetaxel's effective concentration twofold, without affecting cabazitaxel toxicity.

Conclusions:

  • Cabazitaxel demonstrates superior therapeutic efficacy compared to docetaxel in ABCC4-positive prostate cancer cells.
  • ABCC4 is a key determinant of docetaxel resistance.
  • Targeting ABCC4 offers a potential strategy to reverse docetaxel resistance in prostate cancer.

More Related Videos

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...